Previous 10 | Next 10 |
home / stock / seovf / seovf news
(TheNewswire) LONDON, ONTARIO - TheNewswire - October 29, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company, was invited by the TMX Group to present today at the first-ever TSX Life Sciences Investor D...
(TheNewswire) Sernova Retains Integral Wealth Securities for Market Making Services October 27, 2020 9:00 a.m. EDT LONDON, ONTARIO - TheNewswire - October 27, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) , a clinical-stage regen...
(TheNewswire) Sernova to deliver corporate update with focus on value-driving events: technology acquisition, licensing and research collaboration LONDON, ONTARIO - TheNewswire - September 24, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:P...
(TheNewswire) LONDON, ONTARIO - TheNewswire - September 23, 2020 - Sernova Corp. ("Sernova" or the "Company") (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) is pleased to announce that it has closed its non-brokered private placement announced on Septembe...
(via TheNewswire) Sernova to also present Corporate Update as part of Company Presentations L ondon, Ontario - TheNewswire - September 10, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company, announced today th...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - September 9, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) , a clinical-stage regenerative medicine therapeutics company, is pleased to announce that the Company has secured a $2 million lead order in connecti...
(via TheNewswire) Sernova expands its intellectual property portfolio and capabilities to develop first-in-class cell therapy solutions for type 1 diabetes and other chronic diseases that eliminate the need for life-long immunosuppression drugs LONDON, ONTARIO - Augus...
(via TheNewswire) Veteran Pharmaceutical Executive in Regenerative Medicine Therapeutics to Contribute Corporate Development/ Strategic Expertise to Sernova LONDON, ONTARIO - TheNewswire - July 16, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - June 18, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH ), a clinical-stage regenerative medicine therapeutics company, highlights positive results from its submitted abstract entitled "Clinical Validation of the ...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - June 15, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine therapeutics company, is pleased to announce it has completed the acquisition of cellular local immune protection tec...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - July 15, 2024 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment o...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...